Isoflurane is an appropriate anesthetic for neuroanesthesia. We evaluated whether the effect of sevoflurane is similar to that of isoflurane or halothane on brain energy metabolism after cerebral ischemia followed by reperfusion using 31P-magnetic resonance spectroscopy. Wistar rats (n = 21) were divided into three groups: isoflurane-, sevoflurane-, or halothane-treated. After anesthesia induction and surgical preparation, each anesthetic concentration was adjusted to 1 minimum alveolar anesthetic concentration. Cerebral ischemia was induced with bilateral carotid occlusion and reduction of mean arterial blood pressure to 30 -40 mm Hg by blood withdrawal. Magnetic resonance measurements were performed during ischemia and for 120 min of reperfusion. Intracellular pH in the isofluranetreated, sevoflurane-treated, and halothane-treated groups decreased to 6.180 5 0. 149, 6.125 ? 0.134, and 6.027 ? 0.157, respectively, at the end of ischemia. There were no differences in the change of phosphorous compounds and intracellular pH between the isoflurane-treated and the sevoflurane-treated groups during ischemia and reperfusion. However, in the halothane-treated group, we observed a significant delay in the recovery of adenosine triphosphate and intracellular pH (0.038 + 0.013 pH unit/min compared with 0.064 ? 0.011 in the isoflurane-treated group and 0.058 + 0.008 in the sevoflurane-treated group) until 24 min of reperfusion (P < 0.05). We conclude that sevoflurane has effects similar to isoflurane on brain energy metabolism during and after cerebral ischemia. Implications:
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It is important to know whether anesthetics adversely effect brain metabolism during ischemia and reperfusion. A new anesthetic, sevoflurane, affected the brain in a manner similar to isoflurane, which has been used for many years as an anesthetic. (Anesth Analg 1997; 85:593-9) C erebral energy metabolism is affected by a variety of anesthetic related factors. Michenfelder and Theye (1) and Cohen and Marshall (2) reported that administration of more than 2.3% halothane caused a decreased concentration of cerebral phosphorous compounds and an increase of lactic acid. On the other hand, isoflurane at clinical concentrations produces greater depression of cerebral metabolic rate for oxygen (CMRo,) than halothane (3). Moreover, isoflurane has desirable effects on intracranial pressure (ICI') and cerebral blood flow (CBF) compared with halothane. Accordingly, isoflurane has been considered to be a more suitable anesthetic for neurosurgical procedures (4,5).
Sevoflurane, an ether anesthetic, has no pungency (6) and has a relatively low blood-gas partition coefficient of 0.63 (7). Although the use of sevoflurane is still controversial regarding renal toxicity of metabolic products (8,9), ease of emergence makes it suitable for neurosurgery patients, in whom rapid recovery is often desired for postoperative neurological examinations. Takahashi et al. (10) reported that sevoflurane did not affect ICI' in a canine model and concluded that sevoflurane should be a more suitable drug for neuroanesthesia than enflurane or halothane. The effects of sevoflurane on CBF, CMRo,, and electroencephalogram were reported by Scheller et al. (11) to be similar to those of isoflurane in a rabbit model. The objective of this study was to investigate whether sevoflurane at clinical concentrations inhibits cellular energetic pathways and whether sevoflurane has metabolic properties similar to those of isoflurane during cerebral ischemia and the early reperfusion period by Anesth Analg 1997; 85:593-9 593 using 31-phosphorous magnetic resonance spectroscopy (31P-MRS).
Methods
Experiments were performed after approval from our institutional animal care committee. Male Wistar rats (250-300 g) were fasted for 24 h and were then anesthetized with 2-3 minimum alveolar anesthetic concentration (MAC) of inhaled anesthetic sevoflurane (in Experiment 1; sevoflurane, isoflurane, or halothane in Experiment 2) in an induction chamber. After tracheotomy and tracheal intubation, the lungs were mechanically ventilated with anesthetic delivered in 100% 02. Catheters were inserted into the left femoral vein and left femoral artery for blood pressure monitoring and infusion.
For Experiment 2, the carotid arteries were isolated bilaterally. Arterial blood samples were obtained under baseline conditions for measurements of blood gas tensions, plasma glucose, and plasma lactic acid concentrations.
Blood gas tensions and pH were measured by using an ABL3 blood gas analyzer (Radiometer, Copenhagen, Denmark). Plasma glucose and lactic acid were measured by using a YSI 2300STAT glucose/lactate analyzer (Yellow Springs Instruments Co. Inc., Yellow Springs, OH). Lactated Ringer's solution was infused at the rate of 20 mL * kg-' * h-i throughout the experiments. The scalp and pericranial muscles were reflected to position the probe for direct 31P-MRS measurement. After preparation, the rat was fixed to a frame. Pericranial temperature was measured and maintained at approximately 38°C with hot water circulation inside the frame before 31P-MRS measurements were taken. The temperature probe was removed before 31P-MRS measurement to avoid artificial noise interference. Pericranial temperature was measured in a pilot study with a temperature probe placed under the temporalis muscle and controlled with similar measurements at 120 min reperfusion in the present study. Pace, was maintained between 35 and 45 mm Hg. Pancuronium bromide 0.5 mg intravenously was administered for muscle relaxation before measurements were taken. Inspiratory anesthetic concentrations were monitored continuously using a CAPNOMACTM gas analyzer (Datex, Helsinki, Finland) . MAC values were: halothane l.O%, isoflurane 1.5%, and sevoflurane 2.2% (12,13).
Expevimen t 1
According to the above method, six rats were studied. At the end of the surgery, the sevoflurane concentration was adjusted to 1 MAC (2.2%) for at least 1 h. Arterial blood gas tensions and pH and biochemical data were obtained before starting the measurements. After the first 31P-MRS measurement, the concentration of sevoflurane was adjusted to 2 MAC (4.4%). 31P-MRS measurements were performed 1 h later. Phenylephrine was infused iv after the concentration of sevoflurane was adjusted to 2 MAC to maintain mean arterial blood pressure (MAP) within 10% of that at 1 MAC (14,15).
Experiment 2
Cerebral ischemia was induced as described by Haraldseth et al. (16) . Rats were randomly divided into three groups: halothane (n = 7), isoflurane (n = 7), and sevoflurane (n = 7). After surgery, the concentration of each anesthetic was adjusted to 1 MAC for at least 30 min before the start of ischemia. Ischemia was produced by bilateral common carotid occlusion combined with hemorrhagic hypotension (MAP 30 to 40 mm Hg) for 9 min. The carotid clamps were then removed, and the shed blood was reinfused.
Measurements were performed every 3 min for 2 h after the ischemic period.
A vertical wide-bore 6.3T/270 MHz JEOL GSX270-WB spectrometer (Nihon Denshi Co. Inc., Tokyo, Japan) was used for this study. 31P spectra were acquired using a hand-made three-turn surface oval coil of 13 and 15 mm diameter placed directly on the exposed calvarium, for collecting signals from the forebrain. A pulse width of 15 ks was found to give the best signal/noise ratio. Spectra were collected with a 1.2-s repetition time and 120 acquisitions.
After measurements were taken, the broad baseline signal was removed by convolution difference, and the free induction decays were Fourier-transformed after filtering based on exponential function. Phase correction was performed visually in the preischemic spectrum in all spectra for each rat. 31P-MRS spectra of 3-min acquisitions of representative quality from one sevoflurane-anesthetized rat in Experiment 2 are shown in Figure 1 . Intracellular pH (pHi) was calculated from the chemical shift between the peaks for inorganic phosphate (Pi) and phosphocreatine (PCr) using the formula below (17): pHi = 6.77 + log(6 -3.29)/(5. 68 -8) where S is the chemical shift of Pi with respect to PCr. Quantification of the PCr, /3-adenosine triphosphate (ATP), and Pi peaks was performed with area measurements and presented as ratios PCr/PCr,, ATP/ ATP,, and Pi/Pi, where PCr,, ATP,, and Pi, are baseline values independently calculated for each rat. The rate of recovery of pHi in reperfusion was calculated in each rat in pH units per minute as an average from start of reperfusion until the level of pH 7.0 was reached.
All values are presented as the mean t SD. In Experiment 1, statistical analysis was performed using (Table 2 ) before cerebral ischemia were not different among anesthetic groups. MAP decreased rapidly after blood withdrawal and bilateral carotid occlusion and returned to control value after 9 min of ischemia (Fig. 2 ). There were no differences among the three groups for MAP. During ischemia, the pHi decreased to approximately 6.2, and there were no differences among the three groups (halothane group 6.027 ~fr: 0.167, isoflurane group 6.180 + 0.149, sevoflurane group 6.125 f 0.134) (Fig. 3) . However, after reperfusion, pHi was significantly lower in the halothane group than in the isoflurane or sevoflurane group after 6 min of reperfusion. By 18 min of reperfusion, values were similar among groups.
The rate of recovery of pHi was 0.038 + 0.013 pH unit/min in the halothane group compared with 0.064 + 0.011 pH units/min in the isoflurane group (P < 0.01) and 0.058 k 0.008 pH units/min in the sevoflurane group (P < 0.01). After 30 min of reperfusion, pHi recovered to preischemic levels in all three groups.
PCr decreased immediately after cerebral ischemia was induced (Fig. 4 ). There were no significant differences in the recovery of PCr among the groups during the reperfusion period. Within the observed 30 min of reperfusion, PCr recovered to 100% of the preischemic level.
ATP decreased immediately when ischemia was induced (Fig. 5 ). There were no significant differences between the isoflurane and sevoflurane groups. However, in the halothane group, recovery of ATP was depressed between 6 and 21 min after reperfusion relative to the other two anesthetic groups. After 30 min of reperfusion, ATP recovered to approximately 100% of the preischemic baseline in all groups.
Pi, in contrast to high energy phosphate, increased rapidly during ischemia in all three groups (Fig. 6) . No significant differences were observed among the three groups throughout the sequence.
Discussion
Sevoflurane has a lower blood-gas partition coefficient than most inhaled anesthetics, allowing rapid adjustment of anesthetic depth. However, its MAC is relatively high, and a concentration of more than 4% is often administered clinically. (20) concluded that sevoflurane up to 5% did not affect in vitro liver energy metabolism. Our study confirmed these results in rat brain. We administered phenylephrine to maintain systemic blood pressure, because a-adrenergic agonism minimally affects cerebral metabolism and blood flow (14,15). For these reasons, we concluded that clinical concentrations of sevoflurane had less effect on high-energy phosphates than halothane and that it maintained a stable pHi. In Experiment 2, we observed the changes of phosphorous compounds and pHi during cerebral ischemia and after a two-hour reperfusion period. pHi decreases to at least 6.4 when complete cerebral ischemia is induced (21,22). In our study, when two-vessel occlusion and lowering of systemic arterial pressure were performed, pHi was decreased to approximately 6.2 in all groups. Therefore, we were assured that the insult was sufficient to evaluate the differences among the three anesthetics in an hypoxic environment. Sevoflurane showed no differences for phosphorous compounds or intracellular pH compared with isoflurane.
Bickler et al. (23) reported that clinical concentrations of isoflurane directly blocked glutamate receptors. They speculated that isoflurane might have cerebral protective properties by reducing activity of the glutamate receptor. Matsushita et al. (24) recently reported that isoflurane preserved liver cellular ATP in the anoxic environment. They believed that isoflurane augmented glycolysis in the anoxic environment; we believed that this phenomenon might be one of the reasons for the beneficial effect of isoflurane in preserving high-energy phosphorous compounds in living cells. Measurements using 31P-MRS can only indicate changes in the energy state; we could not show the mechanism or effect site. Sevoflurane might have a mechanism for cellular energy metabolic response similar to that of isoflurane.
An interesting finding in our study was the significant delay in recovery of pHi and ATP in the halothane group compared with the other two groups. We did not find any differences in the change of PCr in any group. Creatine kinase, a key enzyme in the Figure  5 . Change in adenosine triphosphate (ATP) for each group in Experiment 2. Values are mean i SD. ATPO = control value before ischemia. * P < 0.05 compared with the isoflurane or sevoflurane group. # P < 0.05 compared with the sevoflurane group. between anesthetics and the creatine kinase system. Further study is therefore necessary. How these differences among anesthetics contribute to outcome after cerebral ischemia is also unclear. Warner et al. (13) reported the comparative effects of sevoflurane and halothane and did not observe any differences in outcome after cerebral ischemia. They induced cerebral ischemia by 90 minutes of middle cerebral artery occlusion. Another study of neurological outcome after sevoflurane anesthesia was reported by Werner et al. (28) . They compared sevoflurane anesthesia with nitrous oxide/ fentanyl anesthesia in 30 minutes of incomplete cerebral ischemia and reported that the outcome was better with sevoflurane anesthesia than with nitrous oxide/ fentanyl anesthesia. These two results show that the depth of anesthesia may be important in defining neurological outcome after cerebral ischemia. The durations of ischemia in both studies were longer than that in our study, which may explain the difference between their results and ours.
Finally, we used 31P-MRS to elucidate the differences in the changes in phosphorous compounds and cellular circumstance among the anesthetics in our study. 3'P-MRS has been used for functional measurements on living tissue, and this technique has provided beneficial information, both sequential and noninvasive, on changes in phosphorus compounds and intracellular events (16,29). In conclusion, 2 MAC sevoflurane did not affect cerebral energy metabolism, and the effect of 1 MAC sevoflurane on brain energy metabolism during cerebral ischemia and reperfusion was quite similar to that of isoflurane. These findings suggest that sevoflurane does not inhibit the recovery of high-energy phosphates during recovery from ischemia in the rat. 
